Soligenix Inc (SNGX)
0.3858
+0.02
(+6.13%)
USD |
NASDAQ |
May 16, 10:31
Soligenix Cash from Financing (Quarterly): -0.009M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.009M |
| December 31, 2023 | -0.0462M |
| September 30, 2023 | -0.1753M |
| June 30, 2023 | 4.816M |
| March 31, 2023 | -0.9316M |
| December 31, 2022 | 0.0768M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.2508M |
| September 30, 2021 | 2.863M |
| June 30, 2021 | 0.0887M |
| March 31, 2021 | 15.86M |
| December 31, 2020 | 11.43M |
| September 30, 2020 | 3.109M |
| June 30, 2020 | 5.618M |
| March 31, 2020 | 4.516M |
| December 31, 2019 | 1.558M |
| September 30, 2019 | 1.637M |
| June 30, 2019 | 0.3044M |
| March 31, 2019 | 0.5052M |
| December 31, 2018 | -0.0598M |
| September 30, 2018 | 8.445M |
| June 30, 2018 | 0.0186M |
| March 31, 2018 | 0.0198M |
| Date | Value |
|---|---|
| December 31, 2017 | 5.153M |
| September 30, 2017 | 0.3979M |
| June 30, 2017 | 0.0231M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 4.543M |
| September 30, 2016 | 3.676M |
| June 30, 2016 | 0.6402M |
| March 31, 2016 | -0.019M |
| December 31, 2015 | 2.224M |
| September 30, 2015 | 0.3408M |
| June 30, 2015 | 1.235M |
| March 31, 2015 | 1.005M |
| December 31, 2014 | 1.938M |
| September 30, 2014 | 0.1711M |
| June 30, 2014 | 0.1692M |
| March 31, 2014 | 0.1583M |
| December 31, 2013 | 0.5735M |
| September 30, 2013 | 0.1768M |
| June 30, 2013 | 6.224M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | |
| December 31, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.9316M
Minimum
Mar 2023
15.86M
Maximum
Mar 2021
2.548M
Average
0.2776M
Median
Cash from Financing (Quarterly) Benchmarks
| Eagle Pharmaceuticals Inc | -6.411M |
| Marinus Pharmaceuticals Inc | 0.257M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 4.974M |
| iBio Inc | 4.005M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.342M |
| Free Cash Flow | -7.780M |
| Free Cash Flow Per Share (Quarterly) | -0.1276 |
| Free Cash Flow to Equity (Quarterly) | -1.078M |
| Free Cash Flow to Firm (Quarterly) | -1.342M |
| Free Cash Flow Yield | -209.2% |